AlphaYouDP
Congress trade
Sen. David Perdue (R-GA) bought $1K-$15K of Pfizer Inc. (PFE) stock
David Perdue, U.S. Senator (R-GA), disclosed a purchase of Pfizer Inc. (PFE) stock worth $1K-$15K in a STOCK Act filing on Mar 1, 2017.
The trade happened on Feb 10, 2017, 19 days before it was made public.
PFE has moved -9.4% since the trade date, from $30.69 to $27.80 (Oct 2, 2026 close).
- Traded
- Feb 10, 2017
- Disclosed
- Mar 1, 2017
- Filing delay
- 19 days
- Price since
- -9.4%
- Source
- STOCK Act disclosure
Other trades in this disclosure (33)
- BuyAMZN$15K-$50KMar 1, 2017
- BuyORCL$15K-$50KMar 1, 2017
- BuyPFE$15K-$50KMar 1, 2017
- SellPG$15K-$50KMar 1, 2017
- SellWOOF$15K-$50KMar 1, 2017
- SellWOOF$15K-$50KMar 1, 2017
- SellBAX$1K-$15KMar 1, 2017
- SellBAX$1K-$15KMar 1, 2017
- SellENTG$1K-$15KMar 1, 2017
- SellENTG$1K-$15KMar 1, 2017
- SellENTG$1K-$15KMar 1, 2017
- SellENTG$1K-$15KMar 1, 2017
- BuyFEYE$1K-$15KMar 1, 2017
- BuyFEYE$1K-$15KMar 1, 2017
- SellFOXA$1K-$15KMar 1, 2017
- SellFOXA$1K-$15KMar 1, 2017
- BuyPFE$1K-$15KMar 1, 2017
- BuyPFE$1K-$15KMar 1, 2017
- BuyPFE$1K-$15KMar 1, 2017
- BuyPFE$1K-$15KMar 1, 2017
More PFE insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.